Drug Database
Back to search

Poland· PL-100463725

Vemonis Ultra

A metamizol, kombinationen, exkl. psycholeptika product containing metamizolum natricum + coffeinum + drotaverini hydrochloridum, registered in Poland by Adamed Pharma S.A..

ATC N02BB52

Checked against URPL (Poland) on

Informational only — not a medical device.

SOURCE REGISTER · PLURPL (Poland)normalisedVemonis UltraATCN02BB52REGISTER NO.PL-100463725PACKS LISTED6CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about metamizolum natricum + coffeinum + drotaverini hydrochloridumAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

The record

At a glance

URPL (Poland)
Active substance
Metamizolum natricum + Coffeinum + Drotaverini hydrochloridum
Manufacturer
Adamed Pharma S.A.
Country
Poland (PL)
ATC code
N02BB52
ATC class
Metamizol, Kombinationen, exkl. Psycholeptika
Reimbursed
Not published by this register
Source register
URPL (Poland)
Last checked
September 27, 2026

Packs & prices · 6

  • gtin
    05909991486389
  • gtin
    05909991486372
  • gtin
    05909991486358
  • gtin
    05909991486365
  • gtin
    05900411013789
  • gtin
    05900411013796

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under N02BB52

Metamizol, kombinationen, exkl. psycholeptika, as other registers publish it.

All metamizol, kombinationen, exkl. psycholeptika products

Authorised across Europe · EMA

The same active substance is authorised in 3 EEA countries. Names it is sold under:

  • Hungary · Algopyrin Trio
  • Romania · Quarelin
  • Slovakia · Quarelin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/7a63f546-1504-40ce-b05b-98ea1d67b397
GET /v1/drugs/7a63f546-1504-40ce-b05b-98ea1d67b397?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tabletki powlekane",
  "source": "urpl",
  "strength": "400 mg + 60 mg + 80 mg",
  "packaging": "05909991486389 ¦ OTC ¦ Skasowane ¦ 145450\n60 tabl.\n05909991486372 ¦ OTC ¦ 145451\n24 tabl.\n05909991486358 ¦ OTC ¦ 145452\n6 tabl.\n05909991486365 ¦ OTC ¦ 145453\n12 tabl.\n05900411013789 ¦ OTC ¦ 162132\n4 tabl.\n05900411013796 ¦ OTC ¦ 162133\n8 tabl.",
  "substance": "Metamizolum natricum monohydricum 421.24 mg + Coffeinum 60 mg + Drotaverini hydrochloridum 80 mg",
  "common_name": "Metamizolum natricum + Coffeinum + Drotaverini hydrochloridum",
  "pl_product_id": "100463725",
  "pozwolenie_nr": "27138",
  "auth_procedure": "NAR",
  "authorisation_validity": "Bezterminowe"
}
API referenceMCP serverPlans

See everything about metamizol, kombinationen, exkl. psycholeptika.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console